NCT06087796Phase 1Status unknown
Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.
Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata: a Clinical and Dermoscopic Study.
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Status unknown
- Declared phase
- Phase 1
- Sponsor
- Assiut University
- Participants (registry)
- 60
- Start
- October 2023
- Primary completion
- September 2024
- Study completion
- October 2024
- Last registry update
- October 2023
- Countries
- Egypt
Conditions studied: Alopecia Areata
Interventions: Betamethasone Valerate 0.1% Cream, Topical betamethasone, Pentoxifylline, topical pentoxifylline, Metformin, Topical metformin
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.